Calendar Tango Therapeutics, Inc.

Equities

TNGX

US87583X1090

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
7.94 USD +3.12% Intraday chart for Tango Therapeutics, Inc. -3.41% -19.80%

Chart calendar Tango Therapeutics, Inc.

a47d0aa7c1914afa3fc.8jPEHjtgkUBZhC9BRv3akSE7YL-B0fb8eJ5aN65Y2_k.ggbwbw1N3QcX9E1xBamtwnNRU46whc_RMco1AN8xrrKba4N7cijfIQ3ceg~b7c09f2a6a2452763d00887cf8ec4f84

Upcoming events on Tango Therapeutics, Inc.

2024-04-07 04:30 pm American Association for Cancer Research Meeting - Abstract No: 558
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Abstract No: 3363
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Abstract No: 3242
2024-04-08 05:30 pm American Association for Cancer Research Meeting - Abstract No: 3916
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract No: 4631
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract No: 4636
2024-04-09 04:30 pm American Association for Cancer Research Meeting - Abstract No: 5584
2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-30 Q4 2024 Earnings Release (Projected)

Past events on Tango Therapeutics, Inc.

2024-03-18 07:00 am Q4 2023 Earnings Release
2024-03-13 09:30 am Barclays Global Healthcare Conference
2024-03-12 03:00 pm Leerink Partners Global Biopharma Conference
2024-02-07 11:30 am Guggenheim Healthcare Talks Biotechnology Conference
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Poster No #: EXTH-63
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Poster NO #: DDDR-33
2023-11-14 Society for Neuroscience Meeting
2023-11-14 08:00 am Jefferies London Healthcare Conference
2023-11-08 07:00 am Q3 2023 Earnings Release
2023-10-31 Society for Immunotherapy of Cancer Meeting
2023-10-14 12:30 pm AACR-NCI-EORTC International Conference - Poster No #: C048
2023-10-13 12:30 pm AACR-NCI-EORTC International Conference - Poster No #: B054
2023-10-13 12:30 pm AACR-NCI-EORTC International Conference - Poster No #: B098
2023-10-13 12:30 pm AACR-NCI-EORTC International Conference - Poster No #: B139
2023-10-13 12:30 pm AACR-NCI-EORTC International Conference - Poster No #: B018
2023-09-11 04:00 pm H.C. Wainwright Global Investment Conference
2023-08-07 07:00 am Q2 2023 Earnings Release
2023-06-14 12:20 pm Goldman Sachs Global Healthcare Conference
2023-06-09 12:15 pm Jefferies Global Healthcare Conference
2023-06-06 10:00 am Annual General Meeting

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


37,0
37,9
-2.3%
24,9
24,8
0.35%
36,5
38,6
-5.42%

32,4

EBITDA
Million USD
Released
Forecast
Spread
0,00


-57,3
-58,9
2.7%
-109
-110
0.26%
-112
-106
-5.46%

-151

EBIT
Million USD
Released
Forecast
Spread
0,00


-58,2
-59,1
1.61%
-111
-112
1.07%
-114
-111
-2.85%

-142

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-57,9
-58,4
0.72%
-108
-110
2.12%
-102
-101
-0.28%

-131

Net income
Million USD
Released
Forecast
Spread
-52,0


-58,2
-59,9
2.84%
-108
-111
2.61%
-102
-100
-1.34%

-131

EPS
USD
Released
Forecast
Spread
-4,53


-0,94
-1,28
26.27%
-1,23
-1,26
2.38%
-1,08
-1,07
-1.41%

-1,27

Announcement Date20/04/2128/03/2227/03/2318/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
5,72
6,57
-13.06%
5,76
5,83
-1.31%
5,77
5,66
1.97%
6,92
5,64
22.64%
6,41
6,32
1.37%
5,77
6,77
-14.83%
14,6
6,95
110.03%
10,7
7,58
41.54%
5,43
8,24
-34.07%

7,87


8,31


8,09


8,12


6,25

EBIT
Million USD
Released
Forecast
Spread
-22,0
-22,6
2.74%
-25,4
-24,0
-5.65%
-25,2
-27,2
7.4%
-29,9
-28,1
-6.66%
-30,6
-31,8
3.79%
-30,3
-31,8
4.9%
-23,2
-31,8
26.79%
-25,6
-32,3
20.66%
-35,0
-30,0
-16.86%

-32,9


-34,2


-35,6


-38,3


-34,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-21,9
-22,3
1.88%
-25,2
-24,8
-1.65%
-24,9
-26,5
6.05%
-29,1
-27,7
-4.75%
-29,0
-31,4
7.5%
-28,0
-31,0
9.55%
-20,6
-26,7
22.75%
-22,2
-30,4
26.85%
-30,7
-29,4
-4.36%

-31,2


-31,9


-33,3


-35,0


-33,5

Net income
Million USD
Released
Forecast
Spread
-22,0
-23,7
7.15%
-25,2
-24,7
-2.26%
-24,9
-27,6
9.84%
-29,1
-28,0
-3.66%
-29,1
-32,0
9.1%
-28,0
-31,8
11.95%
-20,7
-27,7
25.28%
-22,3
-29,8
25.23%
-30,8
-28,6
-7.65%

-31,3


-31,8


-33,1


-34,6


-33,5

EPS
USD
Released
Forecast
Spread
-0,26
-0,27
1.89%
-0,29
-0,28
-5.45%
-0,28
-0,31
9.68%
-0,33
-0,32
-3.94%
-0,33
-0,36
8.33%
-0,32
-0,35
9.22%
-0,23
-0,31
26.59%
-0,23
-0,34
31.34%
-0,30
-0,28
-5.88%

-0,31


-0,32


-0,32


-0,33


-0,32

Announcement Date28/03/2211/05/2210/08/2210/11/2227/03/2309/05/2307/08/2308/11/2318/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise